ORIGINAL ARTICLE Role of impaired glucose tolerance in patients with acute myocardial infarction in relation to sex 467 present in 44% to 69% of the cases. [2] [3] [4] It is known that the population with acute myocardial infarction (AMI) has a high prevalence of glucose and metabolic abnormalities. Diabetes mellitus is detected in 27% to 32% and IGT in 33% to 37% of patients with AMI. [5] [6] [7] In a study by Bartnik et al., 7 glucose tolerance was normal in 35% of the patients with AMI and abnormal (IGT or newly detected diabetes), in 67%. Abnormal glucose tolerance was one of the strongest predictive factors for future major adverse cardiovascular events (MACEs), including
Kowalska et al. 2 showed that postload glucose concentrations significantly correlated with the progression of atherosclerotic lesions in the coronary arteries in patients with stable coronary artery disease undergoing coronary angiography. 2 The risk of cardiovascular diseases can be increased as many as 15 years before diabetes is diagnosed. 8 About 60% of individuals who develop diabetes have either IGT or IFG 5 years before the diagnosis of diabetes. 10 It has been proved that glucose abnormalities are more common in women than in men with AMI, 11 but there are no studies presenting differences in short-or long-term outcome between men and women with AMI and concomitant IGT.
The aim of our study was to assess the shortand long-term outcome in patients with AMI treated with percutaneous coronary intervention (PCI) with concomitant IGT in relation to sex.
PATIENTs ANd mEThOds
The study population was selected from 2733 consecutive patients with AMI treated with primary PCI between 2003 and 2007 . Based on the results of the OGTT, which was performed before discharge, 560 patients with IGT (395 men, 165 women) were selected.
IGT was diagnosed if the blood glucose concentration after 2 hours of the OGTT was from 7.8 mmol/l to less than 11.1 mmol/l.
The clinical data were recorded in a database that represented part of a single-center AMI registry. Information about long-term outcome was collected in a database of the National Fund of Health. The mean follow-up period was 29.4 months.
A comparative analysis was performed between men and women in the whole group with IGT and within high-risk subgroups: patients with low ejection fraction (EF, <35%; n = 413), aged 70 years or older (n = 411), those with incomplete revascularization (ICR; n = 298), and a subgroup with chronic kidney disease (CKD; n = 388). CKD was defined as an estimated glomerular filtration rate (eGFR) of less than 60 ml/min/1.73 m 2 on admission. eGFR was estimated using the Modification of Diet in Renal Disease formula.
ICR was defined when total occlusion or residual stenosis exceeding 70% was observed in any major coronary arteries or their major branches at discharge. Multivessel coronary artery disease was diagnosed when 2 or more major coronary arteries or their major branches were significantly stenosed or occluded. A MACE was defined as the occurrence of death, recurrent myocardial infarction, repeated PCI, coronary artery bypass grafting (CABG), or stroke.
Sex differences were assessed by the χ 2 test for categorical variables and by the t test for continuous variables. Survival curves were constructed using the Kaplan-Meier method and differences in survival were assessed with the log-rank test. Independent predictors of death and MACEs were cardiovascular death, nonfatal myocardial infarction, nonfatal stroke, or severe heart failure. Apart from diabetes, also IGT is associated with an increased cardiovascular risk.
2,8 Therefore, early detection of any abnormalities in glucose metabolism is particularly important.
In a study by Opolski et al., 9 the oral glucose tolerance test (OGTT) was performed only in 13% of the patients with coronary artery disease (in randomly selected primary care offices) within the 15 months preceding the study. Women were significantly older in the CKD group. The differences in survival between men and women in this subgroup are presented in In a multivariate regression analysis, the independent risk factors for death were: age ≥70 years; cardiogenic shock on admission; symptom duration; fibrinogen level; contrast-induced nephropathy; eGFR <60 ml/min/1.73 m 2 ; Thrombolysis in Myocardial Infarction (TIMI) <3 after PCI; multivessel disease; and EF <35% (TAbLE 6) . Sex, ICR, and left main disease did not predict mortality.
Predictors of MACEs included female sex, ICR, and multivessel disease (TAbLE 7) . Reduced EF (<35%), TIMI of less than 3, age of 70 years or older, eGFR of less than 60 ml/min/1.73 m 2 , and hypertension were not independent risk factors. Female sex, prior stroke, or transient ischemic attack, and eGFR of less than 60 ml/min/1.73 m 2 were independent predictors for stroke (TAbLE 7) . dIsCussION An abnormal OGTT test result is an early sign of impaired glucose metabolism. 12 In our study, the OGTT was performed once during hospital stay before discharge. Tenere et al. 13 showed that patients with AMI had no changes in insulin resistance during a 3-month follow-up after hospitalization. OGTT results at discharge were predictors of the outcome of the OGTT during follow-up. 13 In our study, IGT was diagnosed in 20.4% of the patients and diabetes, in 33%. We showed higher total stroke rates in women within the whole group with IGT and in the subgroups with ICR and CKD. The analyses showed significant differences in mortality and MACE rates between men and women in the CKD group. In the whole IGT group, sex was an independent risk factor for MACEs but not for death in the multivariate analysis.
Men had reduced EF and more often had a history of MI. Women were older, had higher total cholesterol and low-density lipoprotein cholesterol levels, as well as lower eGFR on admission. Compared with men, more women were admitted to the hospital with cardiogenic shock, more women had a history of hypertension and atrial fibrillation, their glucose levels were higher on admission, and more often a TIMI of less than 3 was observed. The differences in those parameters were not significant, but their combination could explain higher MACE rates in women.
Different results have been reported by authors who compared mortality in men and women with AMI. In the study by Čulić et al., 14 higher mortality rates were observed in women in the entire population with AMI and in the subgroups of patients aged between 50 and 70 years and those older than 70 years. The female sex was one of the independent predictors of an adverse hospital outcome. In the Acute Myocardial Infarction Hospital Registry Project II (PRIAMHO II), the female sex was an independent risk factor for worse prognosis in the group with AMI. 15 identified with the multivariate Cox-regression model and expressed as hazard ratio with 95% confidence interval. A P value of less than 0.05 was considered significant. All analyses were performed using the Statistica v. 6.1 software (Statsoft Inc., Tulsa, Oklahoma, United States).
REsuLTs
In the whole population with IGT, women were significantly older and more often had hyperlipidemia diagnosed before admission. On the other hand, men had higher rates of previous MI, more often were smokers, and their eGFR on admission was higher. The frequency of prior PCI and CABG did not differ between men and women within the whole population with IGT (TAbLE 1) . Pharmacological treatment after discharge was comparable in men and women with IGT (TAbLE 2) .
A comparative analysis in the whole IGT group showed no differences in mortality during 30-day and 1-year follow-up between men and women. Total mortality was also comparable between the 2 groups. In our study group, the rates of PCI, CABG, AMI, and total MACEs did not differ in men and women during follow-up. We observed only a higher rate of all strokes in women (TAbLE 3) .
A similar analysis was performed for the high--risk subgroups. In women, higher total stroke rates were observed in the ICR subgroup (TAbLE 3) . Total MACE rates and short-or long-term mortality were comparable in the ICR group. Women in this group were also significantly older than men.
We did not observe differences between men and women in the subgroups of patients with low EF (TAbLE 4) and those aged 70 years or older (TAbLE 5) . Short-and long-term mortality, PCI, CABG, AMI, stroke, and total MACE rates as well as age were similar.
Both MACE rates (for 30-day and entire follow-up) and total mortality were higher in women than in men in the CKD subgroup (also, the prevalence of stroke was higher in women), as shown in Abbreviations: MACEs -major adverse cardiac events, others -see TAbLE 1 those factors could not have a significant effect on the outcome. Furthermore, in our study, women in the whole IGT group were older, which did not increase mortality in this group. There have been a number of studies reporting a greater effect of abnormalities in glucose metabolism on cardiovascular risk in women. A meta-analysis of prospective cohort studies proved that a relative risk for fatal coronary heart disease associated with concomitant diabetes was 50% higher in women than in men. 18 In another study, diabetes was associated with a higher risk of death from coronary heart disease (CHD) in women than in men.
19 Kranjčec et al. 20 analyzed patients with acute coronary syndromes. In the group with metabolic syndrome, women
Sielski et al.
16 demonstrated that in patients with non-ST-segment-elevation MI (NSTEMI), long-term prognosis was similar for both sexes, despite the fact that invasive treatment was less frequently used in women.
Heer et al. 17 assessed the outcome in patients after NSTEMI. In-hospital and long-term mortality rates were higher in women, but after the adjustment for age, the differences were not significant. Women in that study were older and were treated less frequently with clopidogrel and PCI. 17 In our population, all patients were treated with PCI and clopidogrel, prehospital delay and the use of glycoprotein IIb/IIIa inhibitors were comparable between men and women in the whole population with IGT. Therefore, factor after STEMI in both sexes, but the effect of impaired renal function on prognosis did not differ between the sexes. 22 Some authors reported that advanced CKD is an independent predictor of in-hospital mortality in the group of patients undergoing PCI in the acute phase of MI. 23 It was impossible to assess in-hospital mortality in our IGT group because the OGTT was performed before discharge. Therefore, some patients died before the OGTT was done. CKD is also a proven risk factor for ischemic stroke. In the study group of 6685 patients with chronic coronary heart disease, a quarter of patients had CKD. In this study, even mild degrees of renal dysfunction were associated with increased risk of ischemic stroke or transient ischemic attack (TIA). 24 Our analysis showed that an eGFR of less than 60 ml/min/1.73 m 2 was one of the independent risk factors for ischemic stroke (with female sex and previous stroke/TIA).
Stroke rates were higher in women within the subgroups with CKD and ICR in our study. In those high-risk groups, women were also older than men. Therefore, the effect of age could not be excluded.
Kisialiou et al. 25 showed that acute ischemic stroke became more frequent in women than in men after the age of 65 years.
Recently, strokes have been reported to occur in older patients. In the study of Park et al., 26 the highest incidence of stroke was noted in people aged 60 and 70 years from 2003 to 2005; between 1994 and 1996, strokes occurred in younger patients.
It is not surprising that, in our study population, women were older than men. It is known that ischemic heart disease occurs earlier in men than in women.
Premenopausal women are protected by estrogens. 27 Vascular mechanisms may reduce abnormal vasoconstriction 28,29 and prevent calcium influx. 29 Estrogen receptors are present in smooth muscle cells in human coronary arteries, thus protecting against atherosclerosis.
28
Our study demonstrated that there are no differences in mortality or total MACE rates between men and women with AMI treated with PCI and concomitant IGT, except for stroke rates in univariate analysis. Also, in the subgroup of patients with ICR and concomitant CKD, stroke rates were higher in women. Additionally, mortality and total MACE rates were higher in women with CKD. It cannot be excluded that higher mortality in women with IGT and CKD could be explained not only by age (women were older than men in this group), but also by a stronger effect of coexisting impaired glucose metabolism and CKD on the outcome in women. In the group of subjects without CKD selected from the Framingham Heart Study offspring cohort, IFG and IGT were associated with a higher risk for the development of CKD compared with normoglycemic subjects. 
Elsayed et al.
30 assessed the effect of obesity on the risk of cardiovascular events (MI and fatal had greater MI than men (determined by peak creatine kinase levels). Patients with metabolic syndrome, particularly women, had a higher rate of heart failure.
Impaired renal function is also related to a greater risk for cardiovascular diseases. Ryan et al.
21 demonstrated a higher risk of cardiovascular mortality with a decrease in eGFR, a marked increase was observed with an eGFR of less than 45 ml/min/1.73 m 2 . In the Korean study, impaired renal function was an independent prognostic coronary heart disease) in patients with CKD. In their study, a higher waist-to-hip ratio was associated with an increased risk of cardiovascular events. Our study shows that coexisting impaired renal function and glucose metabolism may play a great role in increasing cardiovascular and mortality risk. Further research is necessary to investigate the effect of abnormalities in glucose metabolism in patients with CKD or severe atherosclerosis, especially in women. Abbreviations: CI -confidence interval, HR -hazard ratio, others -see TAbLE 1 
